Beaumont Financial Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.06M Hold
15,289
0.08% 146
2025
Q1
$1.06M Sell
15,289
-1,327
-8% -$92.1K 0.08% 142
2024
Q4
$1.43M Buy
16,616
+572
+4% +$49.2K 0.11% 124
2024
Q3
$1.91M Hold
16,044
0.15% 90
2024
Q2
$2.29M Sell
16,044
-350
-2% -$50K 0.18% 81
2024
Q1
$2.1M Buy
16,394
+730
+5% +$93.7K 0.17% 81
2023
Q4
$1.62M Sell
15,664
-920
-6% -$95.2K 0.15% 97
2023
Q3
$1.51M Buy
16,584
+2,950
+22% +$268K 0.15% 97
2023
Q2
$1.08M Hold
13,634
0.1% 123
2023
Q1
$1.08M Sell
13,634
-1,800
-12% -$143K 0.11% 111
2022
Q4
$1.04M Hold
15,434
0.1% 117
2022
Q3
$769K Hold
15,434
0.07% 137
2022
Q2
$860K Hold
15,434
0.08% 135
2022
Q1
$857K Buy
15,434
+1,800
+13% +$99.9K 0.07% 163
2021
Q4
$764K Sell
13,634
-340
-2% -$19.1K 0.06% 167
2021
Q3
$671K Hold
13,974
0.05% 178
2021
Q2
$585K Hold
13,974
0.04% 190
2021
Q1
$471K Hold
13,974
0.04% 202
2020
Q4
$488K Sell
13,974
-6,000
-30% -$210K 0.04% 198
2020
Q3
$693K Hold
19,974
0.07% 170
2020
Q2
$654K Hold
19,974
0.07% 157
2020
Q1
$601K Hold
19,974
0.08% 129
2019
Q4
$578K Buy
19,974
+34
+0.2% +$984 0.06% 168
2019
Q3
$515K Hold
19,940
0.05% 167
2019
Q2
$509K Hold
19,940
0.05% 149
2019
Q1
$522K Sell
19,940
-350
-2% -$9.16K 0.06% 149
2018
Q4
$467K Sell
20,290
-718
-3% -$16.5K 0.08% 130
2018
Q3
$495K Buy
21,008
+3,950
+23% +$93.1K 0.05% 148
2018
Q2
$393K Hold
17,058
0.04% 145
2018
Q1
$420K Buy
17,058
+7,150
+72% +$176K 0.05% 147
2017
Q4
$266K Hold
9,908
0.03% 161
2017
Q3
$239K Buy
+9,908
New +$239K 0.03% 166